Section Review: Oncologic, Endocrine &amp; Metabolic: Thiazolidinediones (Q58197232)

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Regulation of glucose transport by pioglitazone in cultured muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

In vitro studies on the action of CS-045, a new antidiabetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Impaired glucose tolerance in the U.S. population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

The natural history of impaired glucose tolerance in the Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.4.12.1299